00:00:00:00
on-demand WEBINAR
Presented by WellSky and Save the Cord Foundation
Umbilical cord blood transplantation plays a critical role in the treatment of pediatric patients with nonmalignant disorders. Drawing on extensive clinical experience and recent published data, this Share the Science webinar highlights survival rates that have exceeded 90% and emerging best practices that continue to improve transplant success.
An expert in pediatric stem cell transplantation and umbilical cord blood transplantation for immune and nonmalignant disorders.
Dr. Cary Martinez leads one of the nation’s largest pediatric cell therapy and bone marrow transplant programs, where she cares for children with complex immune deficiencies and inherited blood disorders. Her program performs more than 140 bone marrow and cell therapy transplants annually and delivers care in a 25‑bed inpatient transplant unit, serving patients from all 50 states and more than 55 countries.
Her clinical and research focus is on optimizing hematopoietic stem cell transplantation (including umbilical cord blood transplantation), conditioning strategies, and immune recovery. Dr. Martinez holds national leadership roles within cord blood and transplant organizations, leads multicenter studies through the NIH‑funded Primary Immune Deficiency Treatment Consortium (PIDTC), and has authored numerous peer‑reviewed publications in leading journals such as Blood and The Lancet.
Survival rates for pediatric cord blood transplantation
Key findings from North American SCID data
How optimized cord blood unit selection can improve outcome
Why cord blood remains a critical therapeutic resource
WellSky® is one of America’s largest and most innovative healthcare technology companies, leading the movement for intelligent, coordinated care.
In today’s value-based care environment, WellSky connects providers, payers, health systems, life sciences companies, and community organizations through AI-powered software, analytics, and services.
Our solutions help organizations scale smarter, collaborate more effectively, and unlock data-driven insights.
The result is better alignment across all dimensions of clinical and social care — supporting better outcomes and lower costs.
WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations.
With more than 40 years of industry expertise further amplified by AI, WellSky anticipates clients’ needs and innovates relentlessly to shape the future of coordinated care.
For more information, visit wellsky.com.
